Cargando…
A validated method for development of atovaquone as API and tablet dosage forms by UV spectroscopy
A simple new spectrophotometric method has been developed for estimation of Atovaquone in bulk and tablet dosage form. Atovaquone is estimated to be 251 nm in methanol. The Beer's law is obeyed in the concentration range of 1–10 μg/mL of the drug. The slope and intercept values are 0.111 and 0....
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658023/ https://www.ncbi.nlm.nih.gov/pubmed/23781419 http://dx.doi.org/10.4103/2229-4708.72234 |
_version_ | 1782270209882587136 |
---|---|
author | Patel, Kalpesh N Patel, Jayvadan K Patel, Manish P Rajput, Ganesh C |
author_facet | Patel, Kalpesh N Patel, Jayvadan K Patel, Manish P Rajput, Ganesh C |
author_sort | Patel, Kalpesh N |
collection | PubMed |
description | A simple new spectrophotometric method has been developed for estimation of Atovaquone in bulk and tablet dosage form. Atovaquone is estimated to be 251 nm in methanol. The Beer's law is obeyed in the concentration range of 1–10 μg/mL of the drug. The slope and intercept values are 0.111 and 0.012, respectively. Results of analysis of this method have been validated statically and by recovery studies. The method is applied to the marketed tablet formulation. A result of the analysis of tablet formulation, given as a percentage of label claim ± standard deviation, is 99.14 ± 0.66. The precision and accuracy has been examined by performing recovery studies and found to be 100.09 ± 1.14. The developed method is simple, sensitive, and reproducible, and can be used for the routine analysis of Atovaquone in bulk and tablet dosage form. |
format | Online Article Text |
id | pubmed-3658023 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-36580232013-06-18 A validated method for development of atovaquone as API and tablet dosage forms by UV spectroscopy Patel, Kalpesh N Patel, Jayvadan K Patel, Manish P Rajput, Ganesh C Pharm Methods Short Communication A simple new spectrophotometric method has been developed for estimation of Atovaquone in bulk and tablet dosage form. Atovaquone is estimated to be 251 nm in methanol. The Beer's law is obeyed in the concentration range of 1–10 μg/mL of the drug. The slope and intercept values are 0.111 and 0.012, respectively. Results of analysis of this method have been validated statically and by recovery studies. The method is applied to the marketed tablet formulation. A result of the analysis of tablet formulation, given as a percentage of label claim ± standard deviation, is 99.14 ± 0.66. The precision and accuracy has been examined by performing recovery studies and found to be 100.09 ± 1.14. The developed method is simple, sensitive, and reproducible, and can be used for the routine analysis of Atovaquone in bulk and tablet dosage form. Medknow Publications & Media Pvt Ltd 2010 /pmc/articles/PMC3658023/ /pubmed/23781419 http://dx.doi.org/10.4103/2229-4708.72234 Text en Copyright: © Pharmaceutical Methods http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Communication Patel, Kalpesh N Patel, Jayvadan K Patel, Manish P Rajput, Ganesh C A validated method for development of atovaquone as API and tablet dosage forms by UV spectroscopy |
title | A validated method for development of atovaquone as API and tablet dosage forms by UV spectroscopy |
title_full | A validated method for development of atovaquone as API and tablet dosage forms by UV spectroscopy |
title_fullStr | A validated method for development of atovaquone as API and tablet dosage forms by UV spectroscopy |
title_full_unstemmed | A validated method for development of atovaquone as API and tablet dosage forms by UV spectroscopy |
title_short | A validated method for development of atovaquone as API and tablet dosage forms by UV spectroscopy |
title_sort | validated method for development of atovaquone as api and tablet dosage forms by uv spectroscopy |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658023/ https://www.ncbi.nlm.nih.gov/pubmed/23781419 http://dx.doi.org/10.4103/2229-4708.72234 |
work_keys_str_mv | AT patelkalpeshn avalidatedmethodfordevelopmentofatovaquoneasapiandtabletdosageformsbyuvspectroscopy AT pateljayvadank avalidatedmethodfordevelopmentofatovaquoneasapiandtabletdosageformsbyuvspectroscopy AT patelmanishp avalidatedmethodfordevelopmentofatovaquoneasapiandtabletdosageformsbyuvspectroscopy AT rajputganeshc avalidatedmethodfordevelopmentofatovaquoneasapiandtabletdosageformsbyuvspectroscopy AT patelkalpeshn validatedmethodfordevelopmentofatovaquoneasapiandtabletdosageformsbyuvspectroscopy AT pateljayvadank validatedmethodfordevelopmentofatovaquoneasapiandtabletdosageformsbyuvspectroscopy AT patelmanishp validatedmethodfordevelopmentofatovaquoneasapiandtabletdosageformsbyuvspectroscopy AT rajputganeshc validatedmethodfordevelopmentofatovaquoneasapiandtabletdosageformsbyuvspectroscopy |